159 related articles for article (PubMed ID: 32533938)
1. Quantifying the Central Dogma in the p53 Pathway in Live Single Cells.
Hafner A; Reyes J; Stewart-Ornstein J; Tsabar M; Jambhekar A; Lahav G
Cell Syst; 2020 Jun; 10(6):495-505.e4. PubMed ID: 32533938
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of transcription results in accumulation of Wt p53 followed by delayed outburst of p53-inducible proteins: p53 as a sensor of transcriptional integrity.
Blagosklonny MV; Demidenko ZN; Fojo T
Cell Cycle; 2002 Jan; 1(1):67-74. PubMed ID: 12429911
[TBL] [Abstract][Full Text] [Related]
3. p53 Pre- and post-binding event theories revisited: stresses reveal specific and dynamic p53-binding patterns on the p21 gene promoter.
Millau JF; Bastien N; Bouchard EF; Drouin R
Cancer Res; 2009 Nov; 69(21):8463-71. PubMed ID: 19843844
[TBL] [Abstract][Full Text] [Related]
4. Cooperation between ARID3A and p53 in the transcriptional activation of p21WAF1 in response to DNA damage.
Lestari W; Ichwan SJ; Otsu M; Yamada S; Iseki S; Shimizu S; Ikeda MA
Biochem Biophys Res Commun; 2012 Jan; 417(2):710-6. PubMed ID: 22172947
[TBL] [Abstract][Full Text] [Related]
5. Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.
Gomes NP; Bjerke G; Llorente B; Szostek SA; Emerson BM; Espinosa JM
Genes Dev; 2006 Mar; 20(5):601-12. PubMed ID: 16510875
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer.
Sjöström J; Blomqvist C; Heikkilä P; Boguslawski KV; Räisänen-Sokolowski A; Bengtsson NO; Mjaaland I; Malmström P; Ostenstadt B; Bergh J; Wist E; Valvere V; Saksela E
Clin Cancer Res; 2000 Aug; 6(8):3103-10. PubMed ID: 10955790
[TBL] [Abstract][Full Text] [Related]
7. Selective transcription of p53 target genes by zinc finger-p53 DNA binding domain chimeras.
Falke D; Fisher MH; Juliano RL
Biochim Biophys Acta; 2004 Nov; 1681(1):15-27. PubMed ID: 15566940
[TBL] [Abstract][Full Text] [Related]
8. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer.
Salnikow K; Costa M; Figg WD; Blagosklonny MV
Cancer Res; 2000 Oct; 60(20):5630-4. PubMed ID: 11059752
[TBL] [Abstract][Full Text] [Related]
9. Identification of essential transcription factors for adequate DNA damage response after benzo(a)pyrene and aflatoxin B1 exposure by combining transcriptomics with functional genomics.
Smit E; Souza T; Jennen DGJ; Kleinjans JCS; van den Beucken T
Toxicology; 2017 Sep; 390():74-82. PubMed ID: 28882572
[TBL] [Abstract][Full Text] [Related]
10. HBP1-mediated Regulation of p21 Protein through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis.
Chen Y; Pan K; Wang P; Cao Z; Wang W; Wang S; Hu N; Xue J; Li H; Jiang W; Li G; Zhang X
J Biol Chem; 2016 Jun; 291(24):12688-12705. PubMed ID: 27129219
[TBL] [Abstract][Full Text] [Related]
11. Functional interplay between p53 and E2F through co-activator p300.
Lee CW; Sørensen TS; Shikama N; La Thangue NB
Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
[TBL] [Abstract][Full Text] [Related]
12. Transition from in situ to invasive testicular germ cell neoplasia is associated with the loss of p21 and gain of mdm-2 expression.
Datta MW; Macri E; Signoretti S; Renshaw AA; Loda M
Mod Pathol; 2001 May; 14(5):437-42. PubMed ID: 11353054
[TBL] [Abstract][Full Text] [Related]
13. Serine/threonine protein phosphatase type 5 acts upstream of p53 to regulate the induction of p21(WAF1/Cip1) and mediate growth arrest.
Zuo Z; Dean NM; Honkanen RE
J Biol Chem; 1998 May; 273(20):12250-8. PubMed ID: 9575175
[TBL] [Abstract][Full Text] [Related]
14. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
Wunderlich M; Berberich SJ
Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
[TBL] [Abstract][Full Text] [Related]
15. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
16. p53 Binding to the p21 promoter is dependent on the nature of DNA damage.
Hill R; Bodzak E; Blough MD; Lee PW
Cell Cycle; 2008 Aug; 7(16):2535-43. PubMed ID: 18719376
[TBL] [Abstract][Full Text] [Related]
17. Ultraviolet radiation down-regulates expression of the cell-cycle inhibitor p21WAF1/CIP1 in human cancer cells independently of p53.
Wang JA; Fan S; Yuan RQ; Ma YX; Meng Q; Goldberg ID; Rosen EM
Int J Radiat Biol; 1999 Mar; 75(3):301-16. PubMed ID: 10203181
[TBL] [Abstract][Full Text] [Related]
18. p21/CDKN1A mediates negative regulation of transcription by p53.
Löhr K; Möritz C; Contente A; Dobbelstein M
J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
[TBL] [Abstract][Full Text] [Related]
19. The kinetics of p53-binding and histone acetylation at target promoters do not strictly correlate with gene expression after UV damage.
Magrini R; Russo D; Fronza G; Inga A; Menichini P
J Cell Biochem; 2007 Apr; 100(5):1276-87. PubMed ID: 17063487
[TBL] [Abstract][Full Text] [Related]
20. The DEAD-box RNA helicase DDX41 is a novel repressor of p21
Peters D; Radine C; Reese A; Budach W; Sohn D; Jänicke RU
J Biol Chem; 2017 May; 292(20):8331-8341. PubMed ID: 28348086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]